Risperidone Pharmacokinetics in Children With Pervasive Developmental Disorder (PDD)

Summary

The purpose of this research is to study the pharmacokinetics of risperidone in a group of pediatric patients with Pervasive Developmental Disorder (PDD). The study will determine how much risperidone and its breakdown product, 9-hydroxy-risperidone, is in the blood following the patient's usual daily dose. The study is designed to look at how fast children absorb, breakdown, and eliminate risperidone.

Timeline

Start

2001-12

Primary completion

—

Completion

2004-06

Drugs

Indications